To: milton who wrote (7365 ) 11/10/1997 4:05:00 PM From: James Stitt Read Replies (1) | Respond to of 14328
This is really a list of general comments concerning TRIBY rather than a response to milton: I have been watching this bbs for a few months now and while I don't share all the sentiments expressed here I am also bull on TRIBY. Comments: Concerning the price structure, if one considers all the moves triby has made above 3 in the past few months, they have been preceeded by a long low slide, in late may and early september this is evident. Some might call this a head and shoulders development, but from a strictly technical standpoint it can't be classified as such until it closes above the neckline at ~ 3 1/8. In any event, what I feel is key at this point is that the stock never closes below 2 1/2 to 2 3/8, which would indicate a loss of support formed back in july to september. The reason this stock seems to be floundering is what you (we) all seem to be aware of already, namely the warrant expiration. Therefore, we've seen diminishing volume and accompianing diminishing price. However, the general increase in volume in the last 2 months is indicative of interest in the stock and certainly strength. I feel the price will tend to drift up the week before the expiration and perhaps further above 3 afterwards. Market conditions have also hugely affected this stock.Like most other issues, it took a beating during the recent panic, and because of its small typical volume, it will take longer to recover. I am not worried. Triby's income is not worthy of a higher price, in a fundamental sense. I believe that stocks are never under or overvalued, simply because they are valued at what people are willing to pay for them. Having said that, many biotechs are out there losing 5x as much money as triby has made and are selling at 5x the price. The point here is that many mutuals (like Warren Buffett) tend to buy companies for what they make, not what they might make.... Finally, the biggest hurdle this stock needs to overcome is coverage. Because really, stock price is only tenuously linked to the companies behavior. Stocks sell at what people believe they are worth. I hate to bet on other people's opinions, rather than what I see in the company and stock price, but if another brokerage could start coverage, it would do wonders for the price, by changing what people believed the stock was worth, rather than the more difficult, but perhaps more noble effort at building a quality company. I am happy to finally post to this group, and I hope we call all mutually profit from the experience, regardless of my zany opinions... Jim Stitt